Ultrasound-guided sclerotherapy of pingyangmycin for periorbital lymphatic malformations
Abstract Background This study investigated the treatment outcomes of ultrasound-guided sclerotherapy with pingyangmycin for periorbital lymphatic malformations (LMs). Method A retrospective study of patients with periorbital LMs who underwent ultrasound-guided sclerotherapy in our department betwee...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Ophthalmology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12886-025-04154-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850105368748752896 |
|---|---|
| author | Yixiao Li Liang Wang Dan Song Bingxuan Jiao Jing Li Jie Zhou Lei Guo |
| author_facet | Yixiao Li Liang Wang Dan Song Bingxuan Jiao Jing Li Jie Zhou Lei Guo |
| author_sort | Yixiao Li |
| collection | DOAJ |
| description | Abstract Background This study investigated the treatment outcomes of ultrasound-guided sclerotherapy with pingyangmycin for periorbital lymphatic malformations (LMs). Method A retrospective study of patients with periorbital LMs who underwent ultrasound-guided sclerotherapy in our department between 2017 and 2024 was conducted. Results One boy and seven girls with periorbital LMs were analyzed. Four cases had intraorbital lesions, two cases had lesions of the eyelids, and two cases had mixed lesions. Eight children underwent 13 sclerotherapy sessions, fluid was able to be withdrawn with a median amount of aspirate of 2 ml. After treatment, one of the eight children was lesion not seen on imaging, six showed strong improvement, and one showed weak improvement. None of the children experienced procedure-related adverse reactions. Conclusions Ultrasound-guided sclerotherapy is a treatment modality for periorbital LMs with good efficacy and few potential risks. |
| format | Article |
| id | doaj-art-2db37dac5eac475890f36d86caa7b3b8 |
| institution | OA Journals |
| issn | 1471-2415 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Ophthalmology |
| spelling | doaj-art-2db37dac5eac475890f36d86caa7b3b82025-08-20T02:39:07ZengBMCBMC Ophthalmology1471-24152025-05-012511510.1186/s12886-025-04154-0Ultrasound-guided sclerotherapy of pingyangmycin for periorbital lymphatic malformationsYixiao Li0Liang Wang1Dan Song2Bingxuan Jiao3Jing Li4Jie Zhou5Lei Guo6Department of Cheeloo College of Medicine, Shandong UniversityDepartment of Vascular Anomalies and Interventional Radiology, Children’s Hospital Affiliated to Shandong UniversityDepartment of Vascular Anomalies and Interventional Radiology, Children’s Hospital Affiliated to Shandong UniversityDepartment of Vascular Anomalies and Interventional Radiology, Children’s Hospital Affiliated to Shandong UniversityDepartment of Vascular Anomalies and Interventional Radiology, Children’s Hospital Affiliated to Shandong UniversityDepartment of Vascular Anomalies and Interventional Radiology, Children’s Hospital Affiliated to Shandong UniversityDepartment of Vascular Anomalies and Interventional Radiology, Children’s Hospital Affiliated to Shandong UniversityAbstract Background This study investigated the treatment outcomes of ultrasound-guided sclerotherapy with pingyangmycin for periorbital lymphatic malformations (LMs). Method A retrospective study of patients with periorbital LMs who underwent ultrasound-guided sclerotherapy in our department between 2017 and 2024 was conducted. Results One boy and seven girls with periorbital LMs were analyzed. Four cases had intraorbital lesions, two cases had lesions of the eyelids, and two cases had mixed lesions. Eight children underwent 13 sclerotherapy sessions, fluid was able to be withdrawn with a median amount of aspirate of 2 ml. After treatment, one of the eight children was lesion not seen on imaging, six showed strong improvement, and one showed weak improvement. None of the children experienced procedure-related adverse reactions. Conclusions Ultrasound-guided sclerotherapy is a treatment modality for periorbital LMs with good efficacy and few potential risks.https://doi.org/10.1186/s12886-025-04154-0Lymphatic malformationsPeriorbitalSclerotherapyUltrasound-guidedPingyangmycin |
| spellingShingle | Yixiao Li Liang Wang Dan Song Bingxuan Jiao Jing Li Jie Zhou Lei Guo Ultrasound-guided sclerotherapy of pingyangmycin for periorbital lymphatic malformations BMC Ophthalmology Lymphatic malformations Periorbital Sclerotherapy Ultrasound-guided Pingyangmycin |
| title | Ultrasound-guided sclerotherapy of pingyangmycin for periorbital lymphatic malformations |
| title_full | Ultrasound-guided sclerotherapy of pingyangmycin for periorbital lymphatic malformations |
| title_fullStr | Ultrasound-guided sclerotherapy of pingyangmycin for periorbital lymphatic malformations |
| title_full_unstemmed | Ultrasound-guided sclerotherapy of pingyangmycin for periorbital lymphatic malformations |
| title_short | Ultrasound-guided sclerotherapy of pingyangmycin for periorbital lymphatic malformations |
| title_sort | ultrasound guided sclerotherapy of pingyangmycin for periorbital lymphatic malformations |
| topic | Lymphatic malformations Periorbital Sclerotherapy Ultrasound-guided Pingyangmycin |
| url | https://doi.org/10.1186/s12886-025-04154-0 |
| work_keys_str_mv | AT yixiaoli ultrasoundguidedsclerotherapyofpingyangmycinforperiorbitallymphaticmalformations AT liangwang ultrasoundguidedsclerotherapyofpingyangmycinforperiorbitallymphaticmalformations AT dansong ultrasoundguidedsclerotherapyofpingyangmycinforperiorbitallymphaticmalformations AT bingxuanjiao ultrasoundguidedsclerotherapyofpingyangmycinforperiorbitallymphaticmalformations AT jingli ultrasoundguidedsclerotherapyofpingyangmycinforperiorbitallymphaticmalformations AT jiezhou ultrasoundguidedsclerotherapyofpingyangmycinforperiorbitallymphaticmalformations AT leiguo ultrasoundguidedsclerotherapyofpingyangmycinforperiorbitallymphaticmalformations |